Papers

With Tag: Drug Design

Can't find what you are looking for? Add a listing here
Sort By
(0)

A hearty solution for acute myeloid leukemia.

Yiju Hung, H Eugene Liu
Acta Pharmacologica Sinica | 2012 | 10.1038/aps.2011.197

none

(0)

An efficient mechanism for prediction of protein-ligand interactions based on analysis of protein tertiary substructures

Darby Tienhau Chang, Yenjen Oyang, Chienyu Chen, Hsuehfen Juan, Hsuancheng Huang
2004 | 10.1109/BIBE.2004.1317374

none

(0)

Functional and Structural Analysis of a Key Region of the Cell Wall Inhibitor Moenomycin

Yi Zhang, Megan L Bolla, Suzanne Walker, Hirokazu Tsukamoto, Piotr Sliz, Yanqiu Yuan, Shinichiro Fuse, Tsungshing Andrew Wang, Daniel Kahne
ACS Chemical Biology | 2010 | 10.1021/cb100048q

none

(0)

Illuminating the chemistry of life: design, synthesis, and applications of "caged" and related photoresponsive compounds.

Heung M Lee, Daniel R Larson, David S Lawrence
ACS Chemical Biology | 2009 | 10.1021/cb900036s

none

(0)

NGF receptor TrkAd5: Therapeutic agent and drug design target

J J Watson, S J Tyler, D Dawbarn, R L Brady, Christopher Willis, Shelley J Allen, Fahey, Deborah K Shoemark, Ruiqi Zhang
Biochemical Society Transactions | 2006 | 10.1042/BST0340587

none

(0)

MET meets the real world: design issues and clinical strategies in the Clinical Trials Network

Journal of Substance Abuse Treatment | 2002 | 10.1016/S0740-5472(02)00255-6

none

(0)

Design of Optimized Hypoxia-Activated Prodrugs Using Pharmacokinetic/Pharmacodynamic Modeling

Kevin O Hicks, Annika Foehrenbacher, William R Wilson, Timothy W Secomb
2013 | 10.3389/fonc.2013.00314

none

(0)

Structures of human purine nucleoside phosphorylase complexed with inosine and ddI

Biochemical and Biophysical Research Communications | 2004 | 10.1016/j.bbrc.2003.11.179

none

(0)

Novel treatments for anxiety and depression: hurdles in bringing them to the market

Drug Discovery Today | 2001 | 10.1016/S1359-6446(01)02043-8

none

(0)

Isoform-selective histone deacetylase inhibitors

Anton V. Bieliauskas, Mary Kay H. Pflum
Chem. Soc. Rev. | 2008 | 10.1039/B703830P

Histone deacetylase (HDAC) proteins are transcription regulators linked to cancer. As a result, multiple small molecule HDAC inhibitors are in various phases of clinical trials as anti-cancer drugs. The majority of HDAC inhibitors non-selectively influence...

(0)

GPCRpred: an SVM-based method for prediction of families and subfamilies of G-protein coupled receptors

Manoj Bhasin, G P S Raghava
Nucleic Acids Research | 2004 | 10.1093/nar/gkh416

none

(0)

Nutrition and L and K-enteroendocrine cells.

Ruth Gutierrezaguilar, Stephen C Woods
Current Opinion in Endocrinology, Diabetes and Obesity | 2011 | 10.1097/MED.0b013e32834190b5

none

(0)

Learning improved feature rankings through decremental input pruning for support vector based drug activity prediction

Vicente Cerveron, Francesc J Ferri, Wladimiro Diazvillanueva
2010 | 10.1007/978-3-642-13025-0_67

none

(0)

Emetine resistance in Chinese hamster cells is linked genetically with an altered 40S ribosomal subunit protein, S20.

J W Mollenkamp, S Mcgill, D Boersma, D J Roufa
Proceedings of the National Academy of Sciences of the United States of America | 1979 | 10.1073/pnas.76.1.415

none

(0)

Targeted rescue of a destabilized mutant of p53 by an in silico screened drug

Frank M Boeckler, Alan R Fersht, Trevor J Rutherford, Dmitry B Veprintsev, Andreas C Joerger, Gaurav Jaggi
Proceedings of the National Academy of Sciences of the United States of America | 2008 | 10.1073/pnas.0805326105

none

(0)

Opportunities for functional selectivity in GPCR antibodies

Biochemical Pharmacology | 2013 | 10.1016/j.bcp.2012.08.021

none

Can't find what you are looking for? Add a paper here